This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Daniel Santi, MD, PhD
President and Co-founder at ProLynx LLC
Speaker

Profile

Daniel V. Santi, MD, PhD, holds a PhD in Medicinal Chemistry from SUNY and an MD from UCSF (1981). He is currently President of ProLynx LLC, which he co-founded and serves as President, and a Professor at UCSF. Dr. Santi co-founded several biotech companies, including Kosan Biosciences, where he served as CEO and Chairman until its acquisition by Bristol Myers Squibb. Dr. Santi has published over 300 scientific papers and holds numerous patents.

Agenda Sessions

  • Ultra Long-acting Anti-obesity Peptides

    5:00pm